High materiality7/10
Xeris Biopharma price target raised to $12 from $9 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises XERS target to $12; current price $8.78; bullish setup.
- Target: $12; Posted price: $8.78; Firm: Barclays
Key facts
- 01
Target: $12
- 02
Posted price: $8.78
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.